US Contrast Media Injectors Market Analysis, Size, and Share by 2027

Historic Data: 2016-2017   |   Base Year: 2018   |   Forecast Period: 2019-2027

US Contrast Media Injectors Market to 2027 - Country Analysis and Forecasts By Product (Injector Systems, Consumables and Accessories); by Application (Interventional Cardiology, Interventional Radiology and Radiology); and Geography

  • Report Code : TIPRE00003911
  • Category : Life Sciences
  • No. of Pages : 89
Buy Now

The US contrast media injectors market is expected to reach US$ 350.4 Mn in 2027 from US$ 183.8 Mn in 2018. The market is estimated to grow with a CAGR of 7.5% from 2019-2027.



The growth of the market is driven by the factors such as increasing number of approvals for contrast agents and increasing number of patients suffering with chronic diseases. However, the market is likely to get affected due to side effects associated with the contrast media agents during the forecast period.

In an aging society where chronic diseases is a leading factor in the health system, technical advancements are necessary to preserve the quality of life through keeping the affordable prices. Chronic diseases can be defined as medical conditions that lasts for one year or more and requires ongoing medical attention or limit activities of daily living. Chronic diseases such as cancer, heart diseases, musculoskeletal diseases, and others are the leading causes of death and disability that requires several imaging modalities for diagnostic and treatment monitoring purposes. According to the National Center for Chronic Disease Prevention and Health Promotion, chronic diseases takes up US$3.3 trillion in annual health care costs.

Additionally, there presence of robust products in the pipeline have been witnessed in the contrast media injectors market. For instance, Lantheus Medical Imaging, Inc., a US based medical imaging company actively involved in the commercialization of contrast media injectors and agents is undergoing clinical trials to develop Flurpiridaz F 18, a novel PET agent, with the first of two Phase 3 trials complete. Moreover, the company has also collaborated with academic centers in the U.S., Canada and the Europe to investigate fluorine-18-based positron emission tomography (PET) radiopharmaceutical imaging agent designed for molecular imaging of the norepinephrine pathway.

The US contrast media injectors market is segmented based on product and application. Among the product segment, the consumables segment is expected to grow at a significant rate of 7.7% during the forecast period. In addition, the segment is also anticipated to dominate the market by products during the year 2027, with a market share of around 65.0%

 US Contrast Media Injectors Market Revenue and Forecasts to 2027 (US$ Mn)

  • This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

US CONTRAST MEDIA INJECTORS– MARKET SEGMENTATION

By Product

  • Injector Systems
    • MRI Injector Systems
    • CT Injector Systems
    • Angiography Injector Systems
  • Consumables
    • Injector Heads
      • Single Head Injectors
      • Dual Head Injectors
      • Syringe less Injectors
    • Tubing
    • Syringes
    • Other Consumables
  • Accessories

US CONTRAST MEDIA INJECTORS – MARKET SEGMENTATION

By Application

  • Interventional Cardiology
  • Interventional Radiology
  • Radiology

Companies Mentioned

  • Boston Scientific Corporation
  • Shenzhen Xinguan Electromechanical Co. Ltd.
  • ulrich GmbH & Co.KG
  • APOLLO RT Co. Ltd.
  • Bracco Imaging S.p.A.
  • Guerbet SA
  • Cook Medical Incorporated
  • Smiths Medical
  • Sino Medical-Device Technology Co., Ltd.
  • Bayer AG
  • Nemoto Kyorindo Co., Ltd
  • General Electric
  • AngioDynamics

US Contrast Media Injectors Report Scope

Report Attribute Details
Market size in 2018 US$ 183.8 Million
Market Size by 2027 US$ 350.4 Million
Global CAGR (2019 - 2027) 7.5%
Historical Data 2016-2017
Forecast period 2019-2027
Segments Covered By Product
  • Injector Systems
  • Consumables and Accessories
By Application
  • Interventional Cardiology
  • Interventional Radiology and Radiology
Regions and Countries Covered United State
  • United State
Market leaders and key company profiles
  • Boston Scientific Corporation
  • Shenzhen Xinguan Electromechanical Co. Ltd.
  • ulrich GmbH & Co.KG
  • APOLLO RT Co. Ltd.
  • Bracco Imaging S.p.A.
  • Guerbet SA
  • Cook Medical Incorporated
  • Smiths Medical
  • Sino Medical-Device Technology Co., Ltd.
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    us-contrast-media-injectors-market-report-deliverables-img1
    us-contrast-media-injectors-market-report-deliverables-img2
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    US Contrast Media Injectors Market
    Connect With Expert

    The List of Companies

    1. Boston Scientific Corporation
    2. Shenzhen Xinguan Electromechanical Co. Ltd.
    3. ulrich GmbH & Co.KG
    4. APOLLO RT Co. Ltd.
    5. Bracco Imaging S.p.A.
    6. Guerbet SA
    7. Cook Medical Incorporated
    8. Smiths Medical
    9. Sino Medical-Device Technology Co., Ltd.
    10. Bayer AG
    11. Nemoto Kyorindo Co., Ltd
    12. General Electric
    13. AngioDynamics
    us-contrast-media-injectors-market-cagr